Aspire Biopharma Holdings, Inc. (ASBP, ASBPW)

CIK 1847345 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aspire Biopharma Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Sep 9, 20268-K0001493152-26-041918
Sep 8, 20268-K0001493152-26-041725
Aug 19, 20268-K0001493152-26-039135
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005317
Aug 13, 202610-Q0001493152-26-037819
Aug 10, 2026SCHEDULE 13G0001213900-26-087424
Aug 10, 20268-K0001493152-26-036777
Aug 6, 2026SCHEDULE 13G/A0001493152-26-036445
Jul 20, 20268-K0001493152-26-033942
Jul 2, 2026SCHEDULE 13G0002142929-26-000001
Jun 22, 20268-K0001493152-26-029599
Jun 12, 20268-K0001493152-26-028386
Jun 12, 20268-K0001493152-26-028518
May 15, 202610-Q0001493152-26-023802
May 15, 2026SCHEDULE 13G0000919574-26-003204
May 14, 20268-K0001493152-26-023069
May 13, 2026SCHEDULE 13G/A0001213900-26-055622
May 12, 2026DEFR14A0001493152-26-022511
May 8, 2026DEF 14A0001493152-26-022026
Apr 27, 2026PRE 14A0001493152-26-019171
Apr 20, 20268-K0001493152-26-018018
Apr 17, 20268-K/A0001493152-26-017145
Apr 16, 20268-K0001493152-26-017115
Apr 16, 20268-K0001493152-26-017054
Apr 16, 20268-K0001493152-26-016979